SLNO
Price
$48.95
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
33 days until earnings call
VRCA
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
34 days until earnings call
Ad is loading...

SLNO vs VRCA

Header iconSLNO vs VRCA Comparison
Open Charts SLNO vs VRCABanner chart's image
Soleno Therapeutics
Price$48.95
Change-$0.00 (-0.00%)
Volume$248.57K
CapitalizationN/A
Verrica Pharmaceuticals
Price$1.45
Change-$0.00 (-0.00%)
Volume$11.14M
CapitalizationN/A
View a ticker or compare two or three
SLNO vs VRCA Comparison Chart
Loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SLNO vs. VRCA commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNO is a StrongSell and VRCA is a Hold.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (SLNO: $48.95 vs. VRCA: $1.45)
Brand notoriety: SLNO and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNO: 48% vs. VRCA: 973%
Market capitalization -- SLNO: $1.96B vs. VRCA: $61.87M
SLNO [@Biotechnology] is valued at $1.96B. VRCA’s [@Biotechnology] market capitalization is $61.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNO’s FA Score shows that 0 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • SLNO’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNO’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 4 bullish TA indicator(s).

  • SLNO’s TA Score: 4 bullish, 4 bearish.
  • VRCA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VRCA is a better buy in the short-term than SLNO.

Price Growth

SLNO (@Biotechnology) experienced а +0.37% price change this week, while VRCA (@Biotechnology) price change was -13.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

SLNO is expected to report earnings on Nov 06, 2024.

VRCA is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($1.96B) has a higher market cap than VRCA($61.9M). SLNO YTD gains are higher at: 21.615 vs. VRCA (-80.191). SLNO has higher annual earnings (EBITDA): -66.53M vs. VRCA (-77.18M). SLNO has more cash in the bank: 266M vs. VRCA (31.9M). SLNO has less debt than VRCA: SLNO (296K) vs VRCA (46.3M). VRCA has higher revenues than SLNO: VRCA (13.9M) vs SLNO (0).
SLNOVRCASLNO / VRCA
Capitalization1.96B61.9M3,168%
EBITDA-66.53M-77.18M86%
Gain YTD21.615-80.191-27%
P/E RatioN/AN/A-
Revenue013.9M-
Total Cash266M31.9M834%
Total Debt296K46.3M1%
FUNDAMENTALS RATINGS
SLNO vs VRCA: Fundamental Ratings
SLNO
VRCA
OUTLOOK RATING
1..100
7119
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4098
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRCA's Valuation (95) in the Pharmaceuticals Major industry is in the same range as SLNO (99) in the Medical Specialties industry. This means that VRCA’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (65) in the Medical Specialties industry is somewhat better than the same rating for VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew somewhat faster than VRCA’s over the last 12 months.

SLNO's SMR Rating (96) in the Medical Specialties industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

SLNO's Price Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for VRCA (98) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew somewhat faster than VRCA’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNOVRCA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KODK4.860.09
+1.89%
Eastman Kodak Company
BP32.460.09
+0.28%
BP plc
SSTK31.87-0.29
-0.90%
SHUTTERSTOCK
NRT5.28-0.06
-1.22%
North European Oil Royalty Trust
LBTYK21.75-0.37
-1.67%
Liberty Global Ltd

VRCA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRCA has been loosely correlated with TCBP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VRCA jumps, then TCBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCA
1D Price
Change %
VRCA100%
+30.63%
TCBP - VRCA
41%
Loosely correlated
+11.66%
SCPX - VRCA
38%
Loosely correlated
-3.31%
DNA - VRCA
34%
Loosely correlated
+5.32%
EDIT - VRCA
29%
Poorly correlated
-0.62%
SLNO - VRCA
29%
Poorly correlated
-1.47%
More